Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Liberty Energy Inc. Class A common stock (LBRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Liberty Energy Inc. Class A common stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Liberty Energy Inc. Class A common stock trades at $19.08 (market cap $3.08B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 4.1× Liberty Energy Inc. Class A common stock's market cap, and Liberty Energy Inc. Class A common stock pays a 1.91% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Liberty Energy Inc. Class A common stock for 1 Days on average.
| HALO | LBRT | |
|---|---|---|
Market Cap | $12.58B | $3.08B |
Volume | 2,179,278 | 4,917,315 |
Sector | Health | Energy |
52-Week High | $115.22 | $33.93 |
52-Week Low | $61.63 | $11.94 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $4.13B |
Dividend Yield | — | 1.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Liberty Energy Inc. Class A common stock
Liberty Energy provides completion services and technologies for onshore oil, natural gas, and geothermal producers in North America. It also offers distributed power and energy-storage solutions through Liberty Power Innovations.
Read more on LBRT →
